ID

25724

Beschreibung

Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome Concomitant Medication Section (Treatment Phase and Follow-Up)

Stichworte

Versionen (1)
  1. 12.09.17 12.09.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

12. September 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC-ND 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468

Englisch

Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468

1 Formulare  
Patient Information
Beschreibung

Patient Information

Alias
UMLS CUI-1
C1955348
Patient Number
Beschreibung

Patient Number

Datentyp

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Beschreibung

Centre Number

Datentyp

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Visit Day
Beschreibung

Visit Day

Datentyp

date

Maßeinheiten
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C2827038
dd-mmm-yyyy
Concomitant Medication - If Medical History section is included indications on Prior Medication page must correlate utilizing the same terminlogy. Indication on concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology. If a medication was marked continuing at the initial visit (On the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
Beschreibung

Concomitant Medication - If Medical History section is included indications on Prior Medication page must correlate utilizing the same terminlogy. Indication on concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology. If a medication was marked continuing at the initial visit (On the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.

Alias
UMLS CUI-1
C2347852
Are there any concomitant medication CHANGES since the start of the study?
Beschreibung

If "YES", please record all medications used below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0443172
Drug Name (Trade Name Preferred)
Beschreibung

Drug Name

Datentyp

text

Alias
UMLS CUI [1]
C0013227
SINGLE Dose/Unit (e.g. 500mg)
Beschreibung

Dose

Datentyp

text

Alias
UMLS CUI [1]
C3174092
Frequency of this Dose (e.g. BID, PRN)
Beschreibung

Dose Frequency

Datentyp

text

Alias
UMLS CUI [1]
C2826654
Route
Beschreibung

Administration Route

Datentyp

text

Indication
Beschreibung

Indication

Datentyp

text

Alias
UMLS CUI [1]
C3146298
Start Date
Beschreibung

Start Date - As a minimum the year must be started.

Datentyp

date

Maßeinheiten
  • dd-mmm-yyyy
dd-mmm-yyyy
Start Time
Beschreibung

Start Time

Datentyp

time

Maßeinheiten
  • 24hr:min
Alias
UMLS CUI [1]
C1301880
24hr:min
End Date
Beschreibung

End Date

Datentyp

date

Maßeinheiten
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0806020
dd-mmm-yyyy
End Time
Beschreibung

End Time

Datentyp

time

Maßeinheiten
  • 24hr:min
Alias
UMLS CUI [1]
C1522314
24hr:min
Continuiing at end of Study?
Beschreibung

Ongoing

Datentyp

boolean

Alias
UMLS CUI [1]
C0549178
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Visit Day
Item
Visit Day
date
C2827038 (UMLS CUI [1])
Item Group
Concomitant Medication - If Medical History section is included indications on Prior Medication page must correlate utilizing the same terminlogy. Indication on concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology. If a medication was marked continuing at the initial visit (On the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
C2347852 (UMLS CUI-1)
Change of Concomitant Medication
Item
Are there any concomitant medication CHANGES since the start of the study?
boolean
C2347852 (UMLS CUI [1,1])
C0443172 (UMLS CUI [1,2])
Drug Name
Item
Drug Name (Trade Name Preferred)
text
C0013227 (UMLS CUI [1])
Dose
Item
SINGLE Dose/Unit (e.g. 500mg)
text
C3174092 (UMLS CUI [1])
Dose Frequency
Item
Frequency of this Dose (e.g. BID, PRN)
text
C2826654 (UMLS CUI [1])
Item
Route
text
Administration Route
Code List
Route
CL Item
intra-articular (IA)
CL Item
intra-arterial (IAR)
CL Item
intra-dermal (ID)
CL Item
inhalation (IH)
CL Item
intra-muscular (IM)
CL Item
intra-thecal (IT)
CL Item
intra-venous (IV)
CL Item
nasal (NA)
CL Item
oral (PO)
CL Item
rectal (PR)
CL Item
subcutaneous (SC)
CL Item
sublingual (SL)
CL Item
transdermal (TD)
CL Item
topical (TO)
CL Item
vaginal (VA)
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Start Date
Item
Start Date
date
Start Time
Item
Start Time
time
C1301880 (UMLS CUI [1])
End Date
Item
End Date
date
C0806020 (UMLS CUI [1])
End Time
Item
End Time
time
C1522314 (UMLS CUI [1])
Ongoing
Item
Continuiing at end of Study?
boolean
C0549178 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video